Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Nabi (NasdaqNM:NABI)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Financials
Location
5800 Park of Commerce Blvd. NW
Boca Raton, FL 33487
Phone: (561) 989-5800
Fax: (561) 989-5801
Email: invinf@nabi.com
Employees (last reported count): 1,945
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 34%
·Institutional: 43% (65% of float)
(97 institutions)
·Net Inst. Buying: 1.40M shares (+7.94%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Nabi is focused on the discovery, development and commercialization of products that prevent and treat infections and autoimmune diseases. The Company currently has an extensive pipeline of drugs and vaccines in clinical and pre-clinical development and has four marketed biopharmaceutical products: Nabi-HB [Hepatitis B Immune Globulin (Human)], WinRho SDF [Rho (D) Immune Globulin Intravenous (Human)], Autoplex T [Anti-Inhibitor Coagulant Complex, Heat Treated] and Aloprim [(Allopurinol sodium) for injection]. The Company is also a collector and supplier of specialty and non-specific antibody products.
More from Market Guide: Expanded Business Description

Financial Summary
Nabi, a biopharmaceutical company, has a broad product portfolio and significant R&D capabilities focused on the development and commercialization of drugs that prevent and treat infectious and autoimmune diseases. For the six months ended 6/30/01, sales rose 11% to $125.5 million. Net income before extraordinary item rose 35% to $2.2 million. Revenues reflect higher pricing and increased volumes of antibody products. Net income also reflects a higher gross profit.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

David Gury, 62
Chairman, Pres and CEO
$561K--  
Mark Smith, 39
CFO, Sr. VP-Fin.
--  --  
Thomas McLain, 43
Exec. VP, COO
239K--  
Bruce Farley, 50
Sr. VP, Manufacturing Operations
268K--  
David Muth, 47
Sr. VP, Bus. Operations
271K$54K
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:NABIAs of 31-Aug-2001
Price and Volume
52-Week Low
on 20-Dec-2000
$2.50 
Recent Price$6.70 
52-Week High
on 5-Sep-2000
$10.063
Beta-0.31 
Daily Volume (3-month avg)127.3K
Daily Volume (10-day avg)55.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-26.6%
52-Week Change
relative to S&P500
-1.5%
Share-Related Items
Market Capitalization$254.9M
Shares Outstanding38.0M
Float25.1M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$2.11 
Earnings (ttm)$0.12 
Earnings (mrq)$0.04 
Sales (ttm)$6.21 
Cash (mrq)$0.05 
Valuation Ratios
Price/Book (mrq)3.17 
Price/Earnings (ttm)57.27 
Price/Sales (ttm)1.08 
Income Statements
Sales (ttm)$240.8M
EBITDA (ttm)$17.3M
Income available to common (ttm)$4.59M
Profitability
Profit Margin (ttm)1.9%
Operating Margin (ttm)3.0%
Fiscal Year
Fiscal Year EndsDec 30
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)2.11%
Return on Equity (ttm)6.13%
Financial Strength
Current Ratio (mrq)1.88 
Debt/Equity (mrq)1.28 
Total Cash (mrq)$1.95M
Short Interest
As of 8-Aug-2001
Shares Short192.0K
Percent of Float0.8%
Shares Short
(Prior Month)
209.0K
Short Ratio1.78 
Daily Volume108.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.